Leukocare AG:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Leukocare AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10571
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Leukocare AG (Leukocare) is a clinical-stage biotechnology company that offers technologies for stabilizing proteins to increase shelf-life and to facilitate terminal sterilization by irradiation or gas. The company’s services include development of spray drying and spray freeze-drying processes, development of individual SPS formulations meeting individual needs of target proteins, and development of customized lyophilization protocols. It also provides coupling of biological compounds to functionalize surfaces, development of vaccine formulation, and establishment of biological readouts. Leukocare offers its services in the areas of biophysics, physiology, biochemistry, pharmacology, immunology, pharmaceutical technology, chemistry and medical engineering, among others. The company provides its services across Germany. Leukocare is headquartered in Munich, Germany.

Leukocare AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Leukocare AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Leukocare AG, Medical Devices Deals, 2012 to YTD 2018 9
Leukocare AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Leukocare AG, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Trillium Diagnostics Enters Into Licensing Agreement With Leukocare For Sepsis Dx 11
Leukocare and Xellia Pharma Enter into Partnership Agreement 12
Rentschler Biotech Enters into Agreement with Leukocare 13
Leukocare Enters into Agreement with Technical University of Munich 14
Licensing Agreements 15
PaxVax Enters into Licensing Agreement with Leukocare 15
Leukocare AG – Key Competitors 16
Leukocare AG – Key Employees 17
Leukocare AG – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Other Significant Developments 19
Mar 09, 2018: Rentschler Biopharma and Leukocare demonstrate success of strategic alliance for biopharmaceutical development and formulation 19
Sep 14, 2017: LEUKOCARE Continues to Expand and Invests in Research and Development 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Leukocare AG, Pharmaceuticals & Healthcare, Key Facts 2
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Leukocare AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Leukocare AG, Deals By Therapy Area, 2012 to YTD 2018 8
Leukocare AG, Medical Devices Deals, 2012 to YTD 2018 9
Leukocare AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Trillium Diagnostics Enters Into Licensing Agreement With Leukocare For Sepsis Dx 11
Leukocare and Xellia Pharma Enter into Partnership Agreement 12
Rentschler Biotech Enters into Agreement with Leukocare 13
Leukocare Enters into Agreement with Technical University of Munich 14
PaxVax Enters into Licensing Agreement with Leukocare 15
Leukocare AG, Key Competitors 16
Leukocare AG, Key Employees 17

List of Figures
Leukocare AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Leukocare AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Leukocare AG, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Leukocare AG:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Suzhou Xinrong Best Medical Instrument Co Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Suzhou Xinrong Best Medical Instrument Co Ltd (Suzhou Xinrong) is a medical device company that manufactures orthopedic medical instruments. The company offers products such as medullary cavity plug, acetabular screws, metal ball head, stem and titanium plate anterior thoracolumbar fixed equ …
  • aTyr Pharma Inc (LIFE):企業の財務・戦略的SWOT分析
    Summary ATyr Pharma Inc (ATyr Pharma) is a clinical-stage biotechnology company engaged in the discovery and clinical development of medicines for the treatment of cancer and lung diseases. The company’s ATYR1923 is a clinical-stage product candidate, based on the resokine pathway, which binds to th …
  • Airest S.p.A.:企業の戦略・SWOT・財務分析
    Airest S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Airest S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • DHL Supply Chain (formerly Exel Inc.):戦略・SWOT・企業財務分析
    DHL Supply Chain (formerly Exel Inc.) - Strategy, SWOT and Corporate Finance Report Summary DHL Supply Chain (formerly Exel Inc.) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Covalon Technologies Ltd (COV):製品パイプライン分析
    Summary Covalon Technologies Ltd (Covalon) is a researcher, developer and commercialization of medical devices and healthcare technologies. The company offers advanced wound solutions, infection prevention products and perioperative care products. Covalon offers wound care products such as collagen …
  • Olea Medical SA-医療機器分野:企業M&A・提携分析
    Summary Olea Medical SA (Olea Medical), a subsidiary of Toshiba Medical Systems Corp is a healthcare technology company that designs and markets medical imaging software products to healthcare industry. The company’s products include advanced MR and CT perfusion imaging post-processing software prod …
  • The Macerich Co:企業のM&A・事業提携・投資動向
    The Macerich Co - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Macerich Co Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • TClarke Plc (CTO):企業の財務・戦略的SWOT分析
    TClarke Plc (CTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • BioStar Pharmaceuticals Inc (BSPM):企業の財務・戦略的SWOT分析
    Summary BioStar Pharmaceuticals Inc (BioStar) is a developer, manufacturer and marketer of pharmaceutical and healthcare supplement products for various diseases and conditions. The company offers products such as huangyangning tablets, hyperthyroidism capsules, danshen granule, aoxing oleanolic aci …
  • Lepu Medical Technology (Beijing) Co Ltd (300003):製薬・医療:M&Aディール及び事業提携情報
    Summary Lepu Medical Technology (Beijing) Co Ltd (Lepu Medical) is a medical technology company that offers medical equipments, pharmaceutical products and healthcare services. The company’s products include cardiovascular interventional products, surgical cardiology products, peripheral interventio …
  • Verde Science Inc (VRCI):企業の財務・戦略的SWOT分析
    Summary Verde Science Inc (Verde Science), formerly Rango Energy Inc is a pharmaceutical research and development company that explores phytochemicals and drugs to create novel formulations. The company offers research and development services in bioprocess technology, molecular virology and immunol …
  • Intraco Ltd (I06):企業の財務・戦略的SWOT分析
    Intraco Ltd (I06) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Ayala Corp (AC):企業の財務・戦略的SWOT分析
    Ayala Corp (AC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • NEC Capital Solutions Ltd. (8793):企業の財務・戦略的SWOT分析
    NEC Capital Solutions Ltd. (8793) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • ViaCyte Inc-製薬・医療分野:企業M&A・提携分析
    Summary ViaCyte Inc (ViaCyte), formerly Novocell, Inc. is a regenerative medicine company that focuses on the development of cell replacement therapies for the treatment of diabetes. The company’s pipeline product portfolio includes VC-01, which is being developed as a therapy for T1D patients who h …
  • Cre8tek Ltd (FGO):石油・ガス:M&Aディール及び事業提携情報
    Summary Cre8tek Ltd (Cre8tek), formerly Marion Energy Ltd, is an oil and gas exploration and production company. The company explores, acquires, develops, produces and markets oil and gas. It has core operations in Clear Creek field located in the Uinta Basin. Cre8tek also holds interest in the addi …
  • Eastman Chemical Co (EMN):企業の財務・戦略的SWOT分析
    Eastman Chemical Co (EMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Laboratorio Reig Jofre SA (RJF):製薬・医療:M&Aディール及び事業提携情報
    Summary Laboratorio Reig Jofre SA (Reig Jofre) is a pharmaceutical company that researches, develops, manufactures and markets medicinal products and nutritional supplements. The company’s product categories include specialized technology products, specialty therapeutic areas, and consumer healthcar …
  • RHI Magnesita N.V.:企業の戦略・SWOT・財務情報
    RHI Magnesita N.V. - Strategy, SWOT and Corporate Finance Report Summary RHI Magnesita N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Huawei Investment & Holding Co., Ltd.:企業のM&A・事業提携・投資動向
    Huawei Investment & Holding Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Huawei Investment & Holding Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed report …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆